New Pharmatech CEO expects larger external sales – but this won't weaken relationship with Novo Nordisk
Ulla Grove Krogsgaard Thomsen is the new CEO for Novo Nordisk Pharmatech, and according to the CEO, external sales will take up more space in the future. At the same time, she establishes that this will not weaken the firm's relationship with parent company Novo Nordisk.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
Read this article for free
Register with your E-mail. No credit card required.